NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1086 coverIntegrated Molecular Medicine for Neuronal and Neoplastic Disorders Volume 1086 published November 2006
Ann. N.Y. Acad. Sci. 1086: 144–159 (2006). doi: 10.1196/annals.1377.008
Copyright © 2006 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by TAKAO, K.
Articles by MIYAKAWA, T.
Search for Related Content
PubMed
PubMed Citation
Articles by TAKAO, K.
Articles by MIYAKAWA, T.

Part IV. Neuronal Polarity and Psychiatric Disorders

Investigating Gene-to-Behavior Pathways in Psychiatric Disorders

The Use of a Comprehensive Behavioral Test Battery on Genetically Engineered Mice

KEIZO TAKAOa AND TSUYOSHI MIYAKAWAa,b

a Horizontal Medical Research Organization, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan b Institute for Bioinformatics Research and Development (BIRD), JST, Japan

Key Words: comprehensive behavioral test battery • psychiatric diseases • genetically engineered mice • animal model of schizophrenia • calcineurin

Address for correspondence: Tsuyoshi Miyakawa, Ph.D., Horizontal Medical Research Organization, Graduate School of Medicine, Kyoto University, Yoshida Konoe-cho, Kyoto 606-8501, Japan. Voice: +81-75-753-9325; fax: +81-75-753-9281.  e-mail: miyakawa{at}hmro.med.kyoto-u.ac.jp

We have been investigating the relationships between genes and behaviors by conducting a systematic and well-defined behavioral test battery with mice that have a mutation on a gene of interest. The behavioral test battery covers a relatively broad range of various behavioral domains such as learning and memory, sensory-motor functions, emotion, motivation, and drug sensitivity/preference. Recently, we subjected mice lacking calcineurin (CN), a calcium/calmodulin protein phosphatase, to the comprehensive behavioral test battery. The mutant mice had a severe working memory deficit, increased locomotor activity, decreased social interaction, and impairments in prepulse and latent inhibition. The abnormalities of CN mutant mice were strikingly similar to those described for schizophrenic patients. Consistent with these findings, human genetics studies in a large sample of affected families detected a significant association of the PPP3CC gene, which encodes the CN gamma catalytic subunit with schizophrenia. The idea that abnormalities in the CN signaling pathway are involved in schizophrenia pathogenesis is consistent with traditional theories of schizophrenia and with many facts known about schizophrenia. A tremendous amount of knowledge about CN has accumulated and, by utilizing this information, the studies on the pathogenesis/pathophysiology of schizophrenia and its related mental disorders will be potentially accelerated. We discuss the potential impact of a large-scale mouse phenotyping project on the study of psychiatric disorders.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
R. C. Samaco, J. D. Fryer, J. Ren, S. Fyffe, H.-T. Chao, Y. Sun, J. J. Greer, H. Y. Zoghbi, and J. L. Neul
A partial loss of function allele of Methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome
Hum. Mol. Genet., June 15, 2008; 17(12): 1718 - 1727.
[Abstract] [Full Text] [PDF]



footerLeft footerRight